tetano
Editor, Senior Moderator
J Clin Med
. 2021 Jun 27;10(13):2844.
doi: 10.3390/jcm10132844.
Systemic Adverse Events and Use of Antipyretics Predict the Neutralizing Antibody Positivity Early after the First Dose of ChAdOx1 Coronavirus Disease Vaccine
Ji Young Park[SUP] 1 [/SUP], Seong-Ho Choi[SUP] 2 [/SUP], Jin-Won Chung[SUP] 2 [/SUP], Min-Hyung Hwang[SUP] 2 [/SUP], Min-Chul Kim[SUP] 2 [/SUP]
Affiliations
Abstract
Vaccination is considered crucial for the eradication of the coronavirus disease (COVID-19). In our medical center in Korea, most health care workers (HCWs) were vaccinated with the ChAdOx1 COVID-19 vaccine. After vaccination, many HCWs complained of adverse events (AEs). However, it remains unclear whether the production of neutralizing antibodies (NAb) was affected. Therefore, here, we aimed to evaluate AEs and early NAb production in relatively healthy Asians who received the ChAdOx1 vaccine and determine the effect of AEs and antipyretics on early NAb production against COVID-19. Of the 182 Korean HCWs who received the first dose of ChAdOx1 vaccine, 172 (94.5%) experienced ≥1 adverse events and 148 (81.3%) tested positive for NAb 33-40 days after the vaccination. NAb-positive vaccine recipients reported systemic AEs and consumed acetaminophen more frequently than NAb-negative recipients. We identified an association between antibody response and COVID-19 vaccine-related AEs. In conclusion, most ChAdOx1 vaccine recipients reported AEs in our medical center.
Keywords: SARS-CoV-2; health care workers; neutralizing antibodies; vaccination.
. 2021 Jun 27;10(13):2844.
doi: 10.3390/jcm10132844.
Systemic Adverse Events and Use of Antipyretics Predict the Neutralizing Antibody Positivity Early after the First Dose of ChAdOx1 Coronavirus Disease Vaccine
Ji Young Park[SUP] 1 [/SUP], Seong-Ho Choi[SUP] 2 [/SUP], Jin-Won Chung[SUP] 2 [/SUP], Min-Hyung Hwang[SUP] 2 [/SUP], Min-Chul Kim[SUP] 2 [/SUP]
Affiliations
- PMID: 34199053
- DOI: 10.3390/jcm10132844
Abstract
Vaccination is considered crucial for the eradication of the coronavirus disease (COVID-19). In our medical center in Korea, most health care workers (HCWs) were vaccinated with the ChAdOx1 COVID-19 vaccine. After vaccination, many HCWs complained of adverse events (AEs). However, it remains unclear whether the production of neutralizing antibodies (NAb) was affected. Therefore, here, we aimed to evaluate AEs and early NAb production in relatively healthy Asians who received the ChAdOx1 vaccine and determine the effect of AEs and antipyretics on early NAb production against COVID-19. Of the 182 Korean HCWs who received the first dose of ChAdOx1 vaccine, 172 (94.5%) experienced ≥1 adverse events and 148 (81.3%) tested positive for NAb 33-40 days after the vaccination. NAb-positive vaccine recipients reported systemic AEs and consumed acetaminophen more frequently than NAb-negative recipients. We identified an association between antibody response and COVID-19 vaccine-related AEs. In conclusion, most ChAdOx1 vaccine recipients reported AEs in our medical center.
Keywords: SARS-CoV-2; health care workers; neutralizing antibodies; vaccination.